Top

Reactions Weekly

Published in:

01-05-2023 | Cervical Cancer | Case report

Bevacizumab/carboplatin/paclitaxel

Thrombocytopenia: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Maene C, et al. Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer. International Journal of Gynecological Cancer 31: 824-828, No. 6, Jun 2021. Available from: URL: https://ijgc.bmj.com/content/by/year

Title: Bevacizumab/carboplatin/paclitaxel
Thrombocytopenia: case report
Publication date: 01-05-2023
Publisher: Springer International Publishing
Keywords: Cervical Cancer
Cervical Cancer
Thrombocytopenia
Bevacizumab
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38350-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bevacizumab/carboplatin/paclitaxel

Thrombocytopenia: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Hydroxyzine

Abatacept/gold

AZD-1222

Nafcillin

Tozinameran

Multiple drugs